DR-498 Interoperable Multi-Modal Data Platform for AI-Driven Precision Medicine Biomarker Discovery at the Future Medicines Institute

Biomedical data are often poorly standardised and fragmented across formats, limiting integration and slowing the discovery of biomarkers that can improve patient care. The Future Medicines Institute (FMI) at Queen’s University Belfast is developing a precision medicine ecosystem that uses advanced AI/ML approaches to analyse integrated genomics, proteomics, imaging, and clinical datasets. This project will design and evaluate frameworks for multi-modal data harmonisation and AI-driven biomarker discovery. By demonstrating how structured, interoperable data can generate clinically relevant insights, the project aims to accelerate the development of more precise and personalised treatments for patients.

Sarah Maguire , The Queen’s University Belfast, UK